lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance

References

• Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X. Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 2015;361(1):13–21. doi:10.1016/j.canlet.2015.03.00225754818
   PubMed Web of Science ®Google Scholar
• Li PL, Zhang X, Wang LL, et al. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Carcinogenesis. 2015;36(12):1484–1493.26442524
   PubMed Web of Science ®Google Scholar
• Yang AD, Fan F, Camp ER, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006;12(14 Pt 1):4147–4153. doi:10.1158/1078-0432.CCR-06-003816857785
   PubMed Web of Science ®Google Scholar
• Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II study. J Clin Oncol. 2005;23(36):9243–9249. doi:10.1200/JCO.2005.07.74016230673
   PubMed Web of Science ®Google Scholar
• Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22(1):23–30. doi:10.1200/JCO.2004.09.04614665611
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang W, Li N, et al. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis. Carcinogenesis. 2021;42(2):263–271. doi:10.1093/carcin/bgaa09332860508
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu R. lncRNA PART1 promotes breast cancer cell progression by directly targeting miR-4516. Cancer Manag Res. 2020;12:7753–7760. doi:10.2147/CMAR.S24929632922076
   PubMed Web of Science ®Google Scholar
• Li H, Yao G, Zhai J, Hu D, Fan Y. LncRNA FTX promotes proliferation and invasion of gastric cancer via miR-144/ZFX axis. Onco Targets Ther. 2019;12:11701–11713. doi:10.2147/OTT.S22099832021248
   PubMed Web of Science ®Google Scholar
• Wu C, Yang J, Li R, Lin X, Wu J, Wu J. LncRNA WT1-AS/miR-494-3p regulates cell proliferation, apoptosis, migration and invasion via PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer. Onco Targets Ther. 2021;14:891–904. doi:10.2147/OTT.S27823333603394
   PubMed Web of Science ®Google Scholar
• Zhang W, Yuan W, Song J, Wang S, Gu X. LncRna CPS1-IT1 suppresses cell proliferation, invasion and metastasis in colorectal cancer. Cell Physiol Biochem. 2017;44(2):567–580. doi:10.1159/00048509129145177
   PubMedGoogle Scholar
• Qi FF, Yang Y, Zhang H, Chen H. Long non-coding RNAs: key regulators in oxaliplatin resistance of colorectal cancer. Biomed Pharmacother. 2020;128:110329. doi:10.1016/j.biopha.2020.11032932502843
   PubMed Web of Science ®Google Scholar
• Ni Y, Li C, Bo C, et al. LncRNA EGOT regulates the proliferation and apoptosis of colorectal cancer by miR-33b-5p/CROT axis. Biosci Rep. 2020. doi:10.1042/BSR20193893
   Google Scholar
• Sun Y, Liu Y, Cai Y, et al. Downregulation of LINC00958 inhibits proliferation, invasion and migration, and promotes apoptosis of colorectal cancer cells by targeting miR36195p. Oncol Rep. 2020;44(4):1574–1582.32945474
   PubMed Web of Science ®Google Scholar
• Gao R, Fang C, Xu J, Tan H, Li P, Ma L. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145. Arch Biochem Biophys. 2019;663:183–191. doi:10.1016/j.abb.2019.01.00530639170
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113–1121. doi:10.1158/2159-8290.CD-13-020224072616
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li L, Hou Z, et al. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer. Cell Signal. 2020;66:109483. doi:10.1016/j.cellsig.2019.10948331760170
   PubMed Web of Science ®Google Scholar
• Liu A, Liu L, Lu H. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2. J Cell Physiol. 2019;234(8):13747–13761. doi:10.1002/jcp.2805430656681
   PubMed Web of Science ®Google Scholar
• Hui Y, Yang Y, Li D, et al. LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2. Cell Transplant. 2020;29:963689720925059. doi:10.1177/096368972092505932638620
   PubMed Web of Science ®Google Scholar
• Chen R, Zhou S, Chen J, Lin S, Ye F, Jiang P. LncRNA BLACAT1/miR-519d-3p/CREB1 axis mediates proliferation, apoptosis, migration, invasion, and drug-resistance in colorectal cancer progression. Cancer Manag Res. 2020;12:13137–13148. doi:10.2147/CMAR.S27444733376405
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang L, et al. lncRNA HOTAIR contributes to 5FU resistance through suppressing miR-218 and activating NF-kappaB/TS signaling in colorectal cancer. Mol Ther Nucleic Acids. 2020;20:879–880. doi:10.1016/j.omtn.2020.05.01632464550
   PubMedGoogle Scholar
• Li Y, Huang S, Li Y, et al. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells. Tumour Biol. 2016;37(10):14205–14215. doi:10.1007/s13277-016-5254-027553025
   PubMedGoogle Scholar
• Honeywell DR, Cabrita MA, Zhao H, Dimitroulakos J, Addison CL. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One. 2013;8(8):e70515. doi:10.1371/journal.pone.007051523950948
   PubMed Web of Science ®Google Scholar
• Shang JC, Yu GZ, Ji ZW, Wang XQ, Xia L. MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9. Eur Rev Med Pharmacol Sci. 2019;23(14):6160–6169.31364116
   PubMed Web of Science ®Google Scholar
• Shen G, Rong X, Zhao J, et al. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Carcinogenesis. 2014;35(12):2748–2755. doi:10.1093/carcin/bgu20825280563
   PubMed Web of Science ®Google Scholar
• Lu G, Fu D, Jia C, et al. Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer. Oncol Lett. 2017;14(6):7842–7848.29344230
   PubMed Web of Science ®Google Scholar
• Castano Z, San Juan BP, Spiegel A, et al. IL-1beta inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat Cell Biol. 2018;20(9):1084–1097. doi:10.1038/s41556-018-0173-530154549
   PubMed Web of Science ®Google Scholar